Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Conditions

HIV Infections 1Gliosarcoma 1Glioblastoma 1Central Nervous System Neoplasms 1Cachexia 1Acquired Immunodeficiency Syndrome 1

Interventions

testosterone enanthate 1remune 1olanzapine-fluoxetine combination 1irinotecan sucrosofate 1bermekimab 1alkaloid GB18 1Pentoxifylline 1Olanzapine 1Fluoxetine 1Fluorouracil 1Exercise 1Cannabidiol 1Adenosine Triphosphate 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 1 × Cachexia × Pentoxifylline × Clear all
NCT00000646 2021-11-02

Pentoxifylline (Trental) as a Modulator of Tumor Necrosis Factor and of HIV Replication in Patients With AIDS

National Institute of Allergy and Infectious Diseases (NIAID)

Phase 1 Completed
54 enrolled

Acquired Immunodeficiency Syndrome, Cachexia, HIV Infections

Data powered by HemOnc (CC BY 4.0) Colophon âš¡